rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
19
|
pubmed:dateCreated |
2009-10-1
|
pubmed:abstractText |
The neurokinin NK2 receptor is known to pre-exist in equilibrium between at least three states: resting-inactive, calcium-triggering, and cAMP-producing. Its endogeneous ligand, NKA, mainly induces the calcium response. Using a FRET-based assay, we have previously discovered an allosteric modulator of the NK2 receptor that has the unique ability to discriminate among the two signaling pathways: calcium-signaling is not affected while cAMP signaling is significantly decreased. A series of compounds have been prepared and studied in order to better understand the structural determinants of this allosteric functional switch of a GPCR. Most of them display the same allosteric profile, with smooth pharmacomodulation. One compound however exhibits significantly improved modulatory properties of NKA induced signaling when compared to the original modulator.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1520-4804
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:day |
8
|
pubmed:volume |
52
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
5999-6011
|
pubmed:meshHeading |
pubmed-meshheading:19746979-Allosteric Regulation,
pubmed-meshheading:19746979-Animals,
pubmed-meshheading:19746979-Calcium Signaling,
pubmed-meshheading:19746979-Cyclic AMP,
pubmed-meshheading:19746979-Fluorescence Resonance Energy Transfer,
pubmed-meshheading:19746979-Humans,
pubmed-meshheading:19746979-Hydrocarbons, Aromatic,
pubmed-meshheading:19746979-Ligands,
pubmed-meshheading:19746979-Neurokinin A,
pubmed-meshheading:19746979-Protein Conformation,
pubmed-meshheading:19746979-Receptors, G-Protein-Coupled,
pubmed-meshheading:19746979-Receptors, Neurokinin-2,
pubmed-meshheading:19746979-Signal Transduction
|
pubmed:year |
2009
|
pubmed:articleTitle |
Allosteric functional switch of neurokinin A-mediated signaling at the neurokinin NK2 receptor: structural exploration.
|
pubmed:affiliation |
UMR UdS/CNRS 7200, Laboratoire d'Innovation Thérapeutique, Faculté de Pharmacie, Illkirch, France.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|